RadOncAI

Trends

• FDA authorizations extend clinical AI into new specialties and LLMs

Items

1. Jul 15

   FDA clears InformAI's RadOncAI

   The 510(k)-cleared radiation-therapy dose-planning software for head-and-neck cancer, validated on a 900+ patient cohort, generates optimized plans that spare healthy tissue as a clinician co-pilot.